Next Vial review

What it is

Next Vial LLC runs a marketplace platform that connects patients with independently licensed providers through its patient portal; it says it doesn't dispense medication or provide medical care itself. Its FAQ names MD Integrations as the provider network and Manifest Pharmacy in Greer, South Carolina as a pharmacy that may fill prescriptions, and the refund policy lists the company's own address at that pharmacy. Beyond weight loss it sells testosterone (injectable and oral), sermorelin, NAD⁺ by injection or nasal spray, PT-141, B12, glutathione, hair-loss and skincare treatments, erectile-dysfunction and premature-ejaculation medications, and treatments for smoking cessation, herpes, cold sores and acid reflux. It's self-pay only and doesn't take insurance. The site displays a numbered LegitScript certification seal. Support is open from 9 a.m. to 6 p.m. every day.

How it works

You choose a treatment, click to start a visit and answer a short set of medical questions, then upload a photo ID and a selfie, which the FAQ says state rules require. A U.S.-licensed physician from the network reviews your answers, usually within about 24 hours, and some states require a video consultation or live chat, which the doctor arranges. If you're prescribed, the medication ships from an affiliated pharmacy by rush no-contact delivery with no signature needed; you can also ask for the prescription to go to your local pharmacy, though Next Vial can't promise that pharmacy's price. Next Vial serves patients in every state except Alaska. Plans include ongoing provider care, a syringes and alcohol-pad kit, and access to its educational content. Its refund policy says it doesn't currently ship refrigerated products, while its GLP-1 page tells you to keep the medication in the refrigerator once it arrives.

Pricing transparency

On the GLP-1 page, compounded semaglutide is $199 billed monthly on the one-month plan, $507 for three months ($169 a month), $894 for six ($149) and $1,188 for twelve ($99). Compounded tirzepatide is $249 on the one-month plan, $687 for three months ($229), $1,194 for six ($199) and $1,788 for twelve ($149). The price is the same at every dose, there's no monthly membership fee, and shipping is free on orders over $50. A banner further down the same page says plans start "as low as $249.97/month", which conflicts with the plan table, so check the total before you pay. The FAQ says a consultation may be complimentary with your order and that you're billed for medication when it ships. The refund policy treats plans as subscriptions you can cancel in your account before the next shipment; once your card is charged and the package reaches the carrier, all sales are final, and prescription medication can't be returned. Lost packages are reshipped.

Branded vs compounded

For weight loss, Next Vial offers compounded semaglutide and compounded tirzepatide as weekly injections. It states that these are compounded medications that aren't FDA-approved and whose safety and effectiveness the FDA hasn't verified, that it doesn't make them, and that it has no tie to Novo Nordisk or Eli Lilly. Brand-name Wegovy and Zepbound aren't offered. Compounded NAD⁺ comes as an injection or nasal spray at $199 a month on the monthly plan, and sermorelin at $199 a month, neither page stating the dose; injected or inhaled NAD⁺ has no controlled human outcome trials, and sermorelin's long-term outcome data in healthy adults is thin.

Pros and watch-outs

The evidence behind what Next Vial prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Sermorelin benefits: does it work? What the trials show

  A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.

How Next Vial compares

A few alternatives worth a look, depending on what you’re optimizing for.

• MEMEDGm

  Readers who want compounded and brand-name GLP-1 routes presented side by side

  See MEDGm →
• Willow

  Buyers who want every dose priced and the pharmacies named, and will pay more for it

  See Willow →
• Lumen Meds

  Cash buyers who want a low, flat monthly compounded GLP-1 price at every dose, with the pharmacy and clinician network named

  See Lumen Meds →

More GLP-1 telehealth reviews: SexyMD · Solaya MD · VevaRX · Rx.com · No BS RX · Idgie Health